Ab178254 – Ovary Cancer Tissue Array with Progressive Changes, 48 Cases, 96 Samples (1.5Mm), Set 2

ab178254 – Ovary cancer tissue array with progressive changes, 48 cases, 96 samples (1.5mm), set 2

Instructions for Use

Designed for IHC or ISH based protein or RNA tissue profiling in evolution and progression of ovary cancers.

This product is for research use only and is not intended for diagnostic use. Product Overview: ab178254 is an ovary cancer tissue array, set 2, non-overlapping with ab178253, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and TNM stages in duplicates.

Case: 48 Core: 96 Format: 8 rows x 12 columns Size: 1.5mm Thickness: 4µm

All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. There may be >5% tissue core losses for a slide. But retention rate should be >90%.

Notes for use: Bake the slides at 60°C for 30 minutes before use. If antigen retrieval is needed, it is always a good idea to start with a protocol with weak to mild strength. For hints and tips on Immunohistochemistry as well as other techniques please visit www.abcam.com/protocols.

Keep up to date on Abcam events and conferences on Facebook & Twitter.

1 Array Anatomic Stage Age Sex Nature Pathology Grade Position Site (TNM) A01 40 F Ovary Normal Normal A02 27 F Ovary Normal Normal Mucinous A03 19 F Ovary Benign cystadenoma Boderline A04 61 F Ovary Benign mucinous cystadenoma A05 53 F Ovary Benign Thecoma A06 52 F Ovary Benign Thecoma A07 54 F Ovary Benign Thecoma A08 67 F Ovary Benign Thecoma A09 39 F Ovary Benign Thecoma Granulosa cell A10 52 F Ovary Benign tumor Granulosa cell A11 43 F Ovary Benign tumor A12 31 F Ovary Benign Teratoma B01 40 F Ovary Normal Normal B02 27 F Ovary Normal Normal Mucinous B03 19 F Ovary Benign cystadenoma Boderline B04 61 F Ovary Benign mucinous cystadenoma B05 53 F Ovary Benign Thecoma B06 52 F Ovary Benign Thecoma B07 54 F Ovary Benign Thecoma B08 67 F Ovary Benign Thecoma B09 39 F Ovary Benign Thecoma Granulosa cell B10 52 F Ovary Benign tumor Granulosa cell B11 43 F Ovary Benign tumor B12 31 F Ovary Benign Teratoma Serous cystadeno- C01 56 F Ovary Malignant II~III T3N0M1 carcinoma

2 Array Anatomic Stage Age Sex Nature Pathology Grade Position Site (TNM) Serous cystadeno- C02 53 F Ovary Malignant III T3N0M1 carcinoma Serous cystadeno- C03 45 F Ovary Malignant III T2N0M0 carcinoma Endometrioid C04 49 F Ovary Malignant III T1N0M0 adenocarcinoma Serous cystadeno- C05 51 F Ovary Malignant III T1N0M0 carcinoma Serous cystadeno- C06 44 F Ovary Malignant III T2N0M0 carcinoma Serous cystadeno- C07 54 F Ovary Malignant II~III T3N1M1 carcinoma Serous cystadeno- C08 74 F Ovary Malignant III T1N0M0 carcinoma Serous cystadeno- C09 58 F Ovary Malignant III T3N0M1 carcinoma Serous cystadeno- C10 54 F Ovary Malignant III T3N0M1 carcinoma Endometrioid C11 82 F Ovary Malignant II T1N0M0 adenocarcinoma Endometrioid C12 43 F Ovary Malignant I T1N0M0 adenocarcinoma Serous cystadeno- D01 56 F Ovary Malignant II~III T3N0M1 carcinoma Serous cystadeno- D02 53 F Ovary Malignant III T3N0M1 carcinoma Serous cystadeno- D03 45 F Ovary Malignant III T2N0M0 carcinoma Endometrioid D04 49 F Ovary Malignant III T1N0M0 adenocarcinoma Serous cystadeno- D05 51 F Ovary Malignant III T1N0M0 carcinoma Serous cystadeno- D06 44 F Ovary Malignant III T2N0M0 carcinoma Serous cystadeno- D07 54 F Ovary Malignant II~III T3N1M1 carcinoma Serous cystadeno- D08 74 F Ovary Malignant III T1N0M0 carcinoma Serous cystadeno- D09 58 F Ovary Malignant III T3N0M1 carcinoma Serous cystadeno- D10 54 F Ovary Malignant III T3N0M1 carcinoma Endometrioid D11 82 F Ovary Malignant II T1N0M0 adenocarcinoma Endometrioid D12 43 F Ovary Malignant I T1N0M0 adenocarcinoma

3 Array Anatomic Stage Age Sex Nature Pathology Grade Position Site (TNM) Endometrioid E01 52 F Ovary Malignant II T1N0M0 adenocarcinoma Endometrioid E02 44 F Ovary Malignant II~III T1N0M0 adenocarcinoma Endometrioid E03 51 F Ovary Malignant II T1N0M0 adenocarcinoma Endometrioid E04 51 F Ovary Malignant III T1N0M0 adenocarcinoma Endometrioid E05 71 F Ovary Malignant III T3N0M1 adenocarcinoma Endometrioid E06 58 F Ovary Malignant III T3N0M1 adenocarcinoma Endometrioid E07 50 F Ovary Malignant III T1N0M0 adenocarcinoma Endometrioid E08 39 F Ovary Malignant III T2N0M0 adenocarcinoma Endometrioid E09 54 F Ovary Malignant III T3N0M1 adenocarcinoma Endometrioid E10 68 F Ovary Malignant III T1N0M0 adenocarcinoma Mucinous E11 38 F Ovary Malignant cystadeno- I T1N0M0 carcinoma Mucinous E12 18 F Ovary Malignant cystadeno- I T1N0M0 carcinoma Endometrioid F01 52 F Ovary Malignant II T1N0M0 adenocarcinoma Endometrioid F02 44 F Ovary Malignant II~III T1N0M0 adenocarcinoma Endometrioid F03 51 F Ovary Malignant II T1N0M0 adenocarcinoma Endometrioid F04 51 F Ovary Malignant III T1N0M0 adenocarcinoma Endometrioid F05 71 F Ovary Malignant III T3N0M1 adenocarcinoma Endometrioid F06 58 F Ovary Malignant III T3N0M1 adenocarcinoma Endometrioid F07 50 F Ovary Malignant III T1N0M0 adenocarcinoma Endometrioid F08 39 F Ovary Malignant III T2N0M0 adenocarcinoma Endometrioid F09 54 F Ovary Malignant III T3N0M1 adenocarcinoma Endometrioid F10 68 F Ovary Malignant III T1N0M0 adenocarcinoma

4 Array Anatomic Stage Age Sex Nature Pathology Grade Position Site (TNM) Mucinous F11 38 F Ovary Malignant cystadeno- I T1N0M0 carcinoma Mucinous F12 18 F Ovary Malignant cystadeno- I T1N0M0 carcinoma Mucinous G01 48 F Ovary Malignant cystadeno- I T1N0M0 carcinoma Mucinous G02 39 F Ovary Malignant cystadeno- I T3N0M1 carcinoma Mucinous G03 55 F Ovary Malignant cystadeno- I~II T1N0M0 carcinoma Serous cystadeno- G04 48 F Ovary Malignant II T1N0M0 carcinoma Mucinous G05 53 F Ovary Malignant cystadeno- II T1N0M0 carcinoma Clear cell G06 45 F Ovary Malignant II T1N0M0 carcinoma Endodermal sinus G07 23 F Ovary Malignant tumor Endometrioid G08 48 F Ovary Malignant III T1N0M0 adenocarcinoma G09 17 F Ovary Malignant Dysgerminoma G10 61 F Ovary Malignant Dysgerminoma Metastatic colon G11 40 F Ovary Metastasis signet ring cell carcinoma G12 17 F Ovary Malignant Malignant teratoma Mucinous H01 48 F Ovary Malignant cystadeno- I T1N0M0 carcinoma Mucinous H02 39 F Ovary Malignant cystadeno- I T3N0M1 carcinoma Mucinous H03 55 F Ovary Malignant cystadeno- I~II T1N0M0 carcinoma Serous cystadeno- H04 48 F Ovary Malignant II T1N0M0 carcinoma Mucinous H05 53 F Ovary Malignant cystadeno- II T1N0M0 carcinoma 5 Array Anatomic Stage Age Sex Nature Pathology Grade Position Site (TNM) Clear cell H06 45 F Ovary Malignant II T1N0M0 carcinoma Endodermal sinus H07 23 F Ovary Malignant tumor Endometrioid H08 48 F Ovary Malignant III T1N0M0 adenocarcinoma H09 17 F Ovary Malignant Dysgerminoma H10 61 F Ovary Malignant Dysgerminoma Metastatic colon H11 40 F Ovary Metastasis signet ring cell carcinoma H12 17 F Ovary Malignant Malignant teratoma

6 UK, EU and ROW Email: [email protected] | Tel: +44-(0)1223-696000

Austria Email: [email protected] | Tel: 019-288-259

France Email: [email protected] | Tel: 01-46-94-62-96

Germany Email: [email protected] | Tel: 030-896-779-154

Spain Email: [email protected] | Tel: 911-146-554

Switzerland Email: [email protected] Tel (Deutsch): 0435-016-424 | Tel (Français): 0615-000-530

US and Latin America Email: [email protected] | Tel: 888-77-ABCAM (22226)

Canada Email: [email protected] | Tel: 877-749-8807

China and Asia Pacific Email: [email protected] | Tel: 108008523689 (中國聯通)

Japan Email: [email protected] | Tel: +81-(0)3-6231-0940 www.abcam.com | www.abcam.cn | www.abcam.co.jp